The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
Hardvard Health Publishing reports how nonsurgical brain stimulation may be an effective alternative to consider according to a study conducted and puvlished by The BMJ. This alternative is most efficient if medication is not helping to ease the symptoms of depression.
Read the full story here: https://www.health.harvard.edu/newsletter_article/an-underused-option-for-severe-depression
You Might Also Enjoy...
The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
Read about how we use magnetic resonance therapy (MeRT) as a customized use of Transcranial Magnetic Stimulation (TMS).
While TMS is an FDA approved treatment to relieve symptoms of treatment resistant depression, it can be used for many off-label purposes as well.
Historic events have unfolded in the past few year and studies have shown that there is a link between the current state of the news and individual's mental health.
The World Health Organization (WHO) released a scientific brief that stated that there was a dramatic 25% increase in the global prevalence of depression and anxiety during the first year of the COVID-19 pandemic.
Happy Brain Awareness Week! Read more about the effect of different brain chemical messengers and their effect on mental health and every day functioning.